Peter Speelman
Overview
Explore the profile of Peter Speelman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
2444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nuijten M, Keller J, Visser C, Redekop K, Claassen E, Speelman P, et al.
World J Clin Cases
. 2015 Nov;
3(11):935-41.
PMID: 26601096
Aim: To develop a framework for the clinical and health economic assessment for management of Clostridium difficile infection (CDI). Methods: CDI has vast economic consequences emphasizing the need for innovative...
2.
van Nood E, Keller J, Kuijper E, Speelman P
Ned Tijdschr Geneeskd
. 2013 Nov;
157(48):A6580.
PMID: 24279951
Currently available broad spectrum antibiotics are not sufficiently effective against recurrent Clostridium difficile infections (CDI). Donor faecal microbiota transplantation is a very effective treatment for second and recurrent infection but...
3.
van Nood E, Speelman P, Nieuwdorp M, Keller J
Curr Opin Gastroenterol
. 2013 Nov;
30(1):34-9.
PMID: 24241245
Purpose Of Review: To review the current evidence on fecal microbiota transplantations (FMTs) for recurrent Clostridium difficile infections (CDIs), metabolic syndrome and inflammatory bowel disease. Recent Findings: Recently, a randomized...
4.
van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal E, de Vos W, et al.
N Engl J Med
. 2013 Jan;
368(5):407-15.
PMID: 23323867
Background: Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high. We studied the effect of duodenal infusion of donor feces in patients with...
5.
Lammers A, De Porto A, Bennink R, van Leeuwen E, Biemond B, Goslings J, et al.
Am J Hematol
. 2012 Apr;
87(5):484-9.
PMID: 22488175
Asplenic patients are at risk for pneumococcal sepsis. Patients with hyposplenic function, such as associated with sickle cell disease (SCD), are also at risk. However, tests to assess splenic function...
6.
Sijpkens D, Looten D, Corte W, Wiegman A, Speelman P, Romijn J
Ned Tijdschr Geneeskd
. 2011 Dec;
155(47):A3788.
PMID: 22129809
Background: The Dutch Law on Medical Services ('Wet Geneeskundige Behandelingsovereenkomst') of 1995 declares that doctors must adhere to an Informed Refusal (a written Refusal of Medical Treatment) if the patient...
7.
Lammers A, Hoekstra J, Speelman P, Lombarts K
PLoS One
. 2011 Mar;
6(3):e17302.
PMID: 21423748
Background: Current management of asplenic patients is not in compliance with best practice standards, such as defined by the British Committee for Standards in Haematology. To improve quality of care,...
8.
Lammers J, Veninga D, Speelman P, Hoekstra J, Lombarts K
J Hosp Med
. 2010 Jun;
5(8):466-70.
PMID: 20578047
Background: After splenectomy, patients are at increased risk of sepsis with considerable mortality. This risk can be reduced by taking preventive measures, such as prescribing immunizations and antibiotic prophylaxis. Studies...
9.
Verhagen D, Hermanides J, Korevaar J, Bossuyt P, van den Brink R, Speelman P, et al.
Clin Infect Dis
. 2009 Apr;
48(11):1559-65.
PMID: 19392637
Background: The long-term prognosis of endocarditis is described primarily in relation to clinical outcome measures-for example, such complications as cerebrovascular accident, cardiac failure, need for cardiac surgery, relapse rate, and...
10.
Bonta P, Vermeulen J, Speelman P, Prins J
AIDS
. 2008 Jul;
22(12):1522-3.
PMID: 18614879
No abstract available.